| Synonymous names |
| Farnesyl acetate | | 4128-17-0 | | 29548-30-9 | | trans,trans-Farnesyl acetate | | All-trans-Farnesyl acetate | | (2E,6E)-Farnesyl acetate | | [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] acetate | | 3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate | | (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl acetate | | Farnesyl acetate, (2E,6E)- | | (E,E)-farnesyl acetate | | D5ZJ1FOC2I | | 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate, (E,E)- | | 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, 1-acetate | | DTXSID5047110 | | trans-2-trans-6-Farnesyl acetate | | 2,6,10-dodecatrien-1-ol, 3,7,11-trimethyl-, acetate, (2E,6E)- | | UNII-D5ZJ1FOC2I | | DTXSID2047222 | | farneoylacetate | | ((2E,6E)-3,7,11-TRIMETHYLDODECA-2,6,10-TRIENYL) ACETATE | | trans2,trans6-Farnesyl acetate | | E,E-Farnesyl Acetate | | (E)-Farnesyl acetate | | Farnesyl acetate, (E,E)- | | (cis,trans)-Farnesyl acetate | | trans, trans-Farnesyl acetate | | CHEMBL3184169 | | DTXCID0027222 | | DTXCID3027110 | | (2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate | | 2-trans-6-trans-Farnesyl acetate | | CHEBI:186251 | | (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol acetate | | (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl acetate | | trans,trans-Farnesyl acetate, 95% | | Tox21_302688 | | Tox21_303761 | | LMFA07010230 | | MFCD00036516 | | NSC132958 | | s6150 | | AKOS025295075 | | AKOS037646546 | | NSC-132958 | | NCGC00256905-01 | | NCGC00356962-01 | | AS-69473 | | CAS-4128-17-0 | | CAS-29548-30-9 | | HY-128430 | | CS-0099265 | | FEMA NO. 4213, (2E,6E)- | | NS00114121 | | 3,11-Trimethyl-2,6,10-dodecatrienyl acetate | | J-500791 | | 2,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate | | 3,7,11-trimethyldodeca-2,6,10-trien-1-yl acetate | | Q27276136 | | [(E,E)-3,7,11-Trimethyl-2,6,10-dodecatriene-1-yl]ester of acetic acid | | 2,6,10-DODECATRIEN-1-OL, 3,7,11-TRIMETHYL-, 1-ACETATE, (2E,6E)- | | InChI=1/C17H28O2/c1-14(2)8-6-9-15(3)10-7-11-16(4)12-13-19-17(5)18/h8,10,12H,6-7,9,11,13H2,1-5H3/b15-10+,16-12 | | Y7R |
|